Please login to the form below
Oncodesign
This page shows the latest Oncodesign news and features for those working in and with pharma, biotech and healthcare.
Servier, Oncodesign select first preclinical candidate from Parkinson’s disease collaboration
Oncodesign received the first milestone payment in February 2020 as part of the collaboration. ... All told, Servier could pay up to 320m in milestone payments to Oncodesign, as well as royalties on potential future sales.
Latest news
-
Servier and Oncodesign reach first milestone in Parkinson’s partnership
As a result of hitting the first milestone of the programme, Oncodesign receives a success payment of 1m. ... The collaboration works perfectly and both teams are up to the challenges,” said Philippe Genne, CEO and founder of Oncodesign.
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Latest Intelligence
-
Deal Watch January 2016
Staying with oncology, BMS has entered a collaboration with Oncodesign for the development and commercialisation of novel macrocyclin compounds. ... Oncodesign will receive a $3m upfront and will undertake to lead optimisation work with BMS taking over
-
Pharma deals during September 2012
Baxter has an existing equity investment of $50m in Onconova. In a couple of earlier stage deals, Sanofi and Oncodesign have entered into a research collaboration and licence agreement to use ... The Nanocyclix platform will be exclusively applied in
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- EIT Health marks World Cancer Day with €6m pledge for new healthcare delivery models
- World Cancer Day: encouraging men to put their health first
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Strategic behaviour
- Creabilis names Catherine Moukheibir as chairman of the board
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- MIT researchers develop AI model to detect future lung cancer risk
- World Health Organization releases latest set of COVID-19 guidelines
- Neurodiversity and healthcare communications – do we know enough and do we do enough?
PMHub
Porterhouse Medical Group
The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
